Comparison of HE4, CA125, and ROMA Diagnostic Accuracy: A Prospective and Multicenter Study for Chinese Women With Epithelial Ovarian Cancer

• Published in: Medicine (Baltimore) 2015-12, Vol.94 (52), p.e2402-e2402
• Main Authors: Zhang, Pengjun, Wang, Chuanxin, Cheng, Liming, Zhang, Peng, Guo, Lin, Liu, Wanli, Zhang, Zhongying, Huang, Yanchun, Ou, Qishui, Wen, Xinyu, Tian, Yaping
• Format: Article
• Language: English
• Subjects: Adult; Algorithms; Biomarkers, Tumor - blood; CA-125 Antigen - blood; Diagnostic Accuracy Study; Female; Humans; Membrane Proteins - blood; Middle Aged; Ovarian Neoplasms - diagnosis; Prospective Studies; Proteins - analysis; Reproducibility of Results; Sensitivity and Specificity; WAP Four-Disulfide Core Domain Protein 2
• ISSN: 0025-7974; 1536-5964
• DOI: 10.1097/MD.0000000000002402

Risk of Ovarian Malignancy Algorithm (ROMA) combing human epididymis secretary protein 4 (HE4) and CA125 showed better diagnostic accuracy for epithelial ovarian cancer (EOC) when compared with HE4 or CA125 alone; however, other studies showed no or worse diagnostic accuracy. We aim to conduct a prospective and multicenter clinical trial to compare the diagnostic accuracy of HE4, CA125, and ROMA for EOC.A prospective and multicenter (n = 9) trial including 2481 individuals was performed in Chinese women. HE4, CA125, and ROMA diagnostic accuracy were evaluated according to different menopausal status and stages of EOC. Their diagnostic values were evaluated by the area under curve (AUC) and compared by the Z scores. Diagnostic specificity of other kinds of participants (n = 1098) was also evaluated.For discriminating between healthy control (HC) and EOC, only CA125 showed significant difference for discriminating HC and EOC in all the individuals when compared with HE4 and ROMA (P